Orio Therapeutics SA
PrivateLast Round
Grant
Jun 3, 2024
Total Funding Raised
$720,000
Company Overview
Orio Therapeutics SA operates in Healthcare & Life Sciences and is based in Monthey. Its latest recorded funding round was a Grant round in June 2024.
Orio Therapeutics SA is a biotechnology company developing regenerative drugs using protein engineering and targeted drug-delivery technologies, with an initial focus on a cardioprotective therapy for heart attack patients.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Orio Therapeutics SA Comparables
Compare Orio Therapeutics SA with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Regencor | 79% | |
| TargaCell Corporation | 76% | |
| AI Proteins | 63% |
For institutional investors. Book with your work email.
Orio Therapeutics SA Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 3, 2024 | ||||
| Pre Seed | Apr 4, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Orio Therapeutics SA Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Venture Kick | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
Monthly visitors increased 74% MoM, reaching 3.2K.
- May 2, 2025
Monthly visitors increased 156% MoM, reaching 1.7K.
For institutional investors. Book with your work email.
Orio Therapeutics SA Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Orio Therapeutics SA's valuation, stock price, and market status.
Is Orio Therapeutics SA a public or private company?
Orio Therapeutics SA is a private company.
What is the current stock price of Orio Therapeutics SA?
Orio Therapeutics SA is a private company, so its shares have no public market price. Caplight tracks Orio Therapeutics SA's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Orio Therapeutics SA worth (valuation)?
Valuation information for Orio Therapeutics SA is not publicly available.
Can I buy Orio Therapeutics SA stock?
Orio Therapeutics SA shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Orio Therapeutics SA's last funding round?
Orio Therapeutics SA's most recent funding round was Grant on June 3, 2024.
Who are the main investors in Orio Therapeutics SA?
Key investors in Orio Therapeutics SA include Venture Kick.
Will Orio Therapeutics SA IPO soon?
No public IPO plans have been announced for Orio Therapeutics SA.
How can I track Orio Therapeutics SA secondary market activity?
Caplight tracks bids, offers, and trades in Orio Therapeutics SA's shares on secondary markets.